OCUP +110%/PM on phase-3 success in reversal of drug-induced pupil dilation: https://www.globenewswire.com/news-release/2021/03/15/2192556/0/en/Ocuphire-Announces-MIRA-2-Phase-3-Registration-Trial-for-the-Reversal-of-Mydriasis-Meets-Primary-Endpoint.html OCUP is the result of a reverse-merger announced in Jun 2020 (#msg-156362145).